Chief Executive Officer
CurrentAs CEO and Executive Member of the Board of Directors at Oralucent, Hans Kaspersetz is leading the company’s mission to revolutionize oral care through its innovative light therapy technology. With over 24 years of experience in healthcare marketing, particularly in biotech and medical devices, Hans is uniquely positioned to drive the adoption of light therapy for home use. His personal mission to help people live longer, healthier lives fuels his leadership, guiding Oralucent’s ambitious growth strategy. In just four months, he successfully raised a key round of capital, setting the foundation for the company’s aggressive expansion.Hans oversees Oralucent’s overall strategy, capital raising, and financial health, ensuring alignment between product development and market execution. He leads the company’s efforts in executive development, corporate development, and global infrastructure to drive long-term success. His experience in M&A, investor relations, and strategic partnerships is pivotal in scaling the company’s presence in both domestic and global markets, positioning Oralucent as a leader in oral care innovation.In addition to financial and strategic oversight, Hans is dedicated to building a high-performing executive team and fostering a culture focused on consumer needs. He emphasizes collaboration and innovation, ensuring that the company’s products are accessible and aligned with consumer demands. Hans’s leadership ensures that Oralucent remains agile and responsive, while driving long-term growth.Under his guidance, Oralucent is poised to grow rapidly. By leveraging his expertise in new business development, product innovation, and global expansion, Hans is steering Oralucent to redefine the oral care landscape and make light therapy a central part of home-based oral health solutions.